Monica Boen
Dermatology · San Diego, CANPI 1508203563
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,022 of the $7,682 with a category attached, or 65.4%. 24 manufacturers reported payments, led by AbbVie at 24.8% of the total.
Across 189 payments — averaging $40.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Merz North America, Inc.$2K
- Biofrontera Inc.$2K
- Galderma Laboratories, L.p.$532
- Pfizer$271
- Lilly USA, LLC$216
- plus $1K from 18 others
Across 21 payments — averaging $7706.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biofrontera Inc.$123K
- Sanofi US Services Inc.$20K
- AbbVie$19K
What the payments were for
- Speaking & faculty fees$1,50020%
- Travel & lodging$1,14115%
- Food & beverage$5,02265%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 83 | $1,906 |
| Merz North America, Inc. | 9 | $1,792 |
| Biofrontera Inc. | 13 | $1,710 |
| Galderma Laboratories, L.p. | 18 | $532 |
| Pfizer | 13 | $271 |
| Lilly USA, LLC | 10 | $216 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $172 |
| LEO Pharma Inc. | 7 | $156 |
| Revance Therapeutics, Inc. | 5 | $141 |
| Incyte Corporation | 6 | $116 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $109 |
| Acelrx Pharmaceuticals, Inc. | 1 | $103 |
| Johnson & Johnson | 4 | $83 |
| Sun Pharmaceutical Industries Inc. | 3 | $70 |
| Amgen | 1 | $45 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| Tactile Systems Technology Inc | 2 | $37 |
| VYNE Pharmaceuticals Inc. | 2 | $36 |
| Sanofi | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Almirall LLC | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $21 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Strata Skin Sciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,682 in reported general payments places this provider in the 75th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 17 | $82 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Diego
- Neal BhatiaSan Diego$2.5M
- Arisa OrtizSan Diego$261K
- Michael BradshawSan Diego$143K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.